Covidien board approves company's restructuring plan

09/20/2013 | American City Business Journals

A restructuring effort that could save Covidien up to $300 million per year has been approved by the company's board, according to a regulatory filing. The plan, which includes consolidation of the company's manufacturing sites and distribution facilities, could be finalized by the close of fiscal year 2018.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care